Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Lung Cancer, Non-Small Cell
Interventions
DRUG

Pazopanib (GW786034)

Pazopanib monotherapy

Trial Locations (13)

14263

GSK Investigational Site, Buffalo

18840

GSK Investigational Site, Sayre

19106

GSK Investigational Site, Philadelphia

23601

GSK Investigational Site, Newport News

32806

GSK Investigational Site, Orlando

33916

GSK Investigational Site, Fort Myers

43219

GSK Investigational Site, Columbus

55805

GSK Investigational Site, Duluth

70809

GSK Investigational Site, Baton Rouge

74136

GSK Investigational Site, Tulsa

85258

GSK Investigational Site, Scottsdale

98109

GSK Investigational Site, Seattle

78463-3069

GSK Investigational Site, Corpus Christi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00549328 - Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter